These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 26135593)
1. Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects. Toublanc N; Du X; Liu Y; Chen Q; Singh P; Chan R; Stockis A Clin Drug Investig; 2015 Aug; 35(8):495-503. PubMed ID: 26135593 [TBL] [Abstract][Full Text] [Related]
2. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects. Wang M; Wang M; Zhang Q; Zong S; Lv C Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):405-413. PubMed ID: 29383569 [TBL] [Abstract][Full Text] [Related]
4. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets. Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the antiepileptic drug levetiracetam in healthy Japanese and Caucasian volunteers following intravenous administration. Toublanc N; Okagaki T; Boyce M; Chan R; Mugitani A; Watanabe S; Yamamoto K; Yoshida K; Andreas JO Eur J Drug Metab Pharmacokinet; 2015 Dec; 40(4):461-9. PubMed ID: 25283522 [TBL] [Abstract][Full Text] [Related]
6. Bioequivalence study of the antiepileptic drug levetiracetam in concentrated solution for injection versus oral tablets in healthy Chinese subjects under fasting conditions: A randomized, open-label, three-way crossover study . Xu J; Zhao X; Wang Z; Zhou Y; Yang X; Cui Y Int J Clin Pharmacol Ther; 2018 Nov; 56(11):555-561. PubMed ID: 30168416 [TBL] [Abstract][Full Text] [Related]
7. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
8. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975 [TBL] [Abstract][Full Text] [Related]
9. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers. Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605 [TBL] [Abstract][Full Text] [Related]
10. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers. Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605 [TBL] [Abstract][Full Text] [Related]
11. Bioequivalence of a novel minitablet formulation of levetiracetam. de Mey C; Dimitrova V; Lennartz P; Wangemann M Arzneimittelforschung; 2012 Feb; 62(2):94-8. PubMed ID: 22344554 [TBL] [Abstract][Full Text] [Related]
13. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study. Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895 [TBL] [Abstract][Full Text] [Related]
14. Bioequivalence and Safety of Levetiracetam Granules and Oral Solution: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under a Fasting Condition. Liu Y; Zou Y; Wang Y; Jiang F; Xu W; Liu S; Jia J; Yu C; Fang L; Hu L; Zhang KE; Long J; Pu H Clin Pharmacol Drug Dev; 2022 Mar; 11(3):372-378. PubMed ID: 35157781 [TBL] [Abstract][Full Text] [Related]
15. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490 [TBL] [Abstract][Full Text] [Related]
16. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules. Snoeck E; Jacqmin P; Sargentini-Maier ML; Stockis A Epilepsy Res; 2007 Sep; 76(2-3):140-7. PubMed ID: 17851036 [TBL] [Abstract][Full Text] [Related]
17. Randomized Comparative Bioavailability of a Novel Three-Dimensional Printed Fast-Melt Formulation of Levetiracetam Following the Administration of a Single 1000-mg Dose to Healthy Human Volunteers Under Fasting and Fed Conditions. Boudriau S; Hanzel C; Massicotte J; Sayegh L; Wang J; Lefebvre M Drugs R D; 2016 Jun; 16(2):229-38. PubMed ID: 27028750 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of levetiracetam after oral and intravenous administration of a single dose to clinically normal cats. Carnes MB; Axlund TW; Boothe DM Am J Vet Res; 2011 Sep; 72(9):1247-52. PubMed ID: 21879984 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
20. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials. Godfrey AR; Digiacinto J; Davis MW Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]